Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18562077 | 0.88 | MEN1 (0.38) | MEN1HCRTR1ALDH1A1LMNAMAPT | |
| SCHEMBL5716470 | 0.86 | MEN1 (0.37) | MEN1HCRTR1ALDH1A1LMNAMAPT | |
| SCHEMBL12310914 | 0.85 | MEN1 (0.39) | MEN1HCRTR1ALDH1A1LMNAMAPT | |
| SCHEMBL5716591 | 0.81 | ALDH1A1 (0.34) | MEN1HCRTR1ALDH1A1LMNAMAPT | |
| SCHEMBL18546564 | 0.77 | ALDH1A1 (0.35) | MEN1HCRTR1ALDH1A1LMNAMAPT | |
| SCHEMBL22909443 | 0.76 | — | — | |
| SCHEMBL12326406 | 0.74 | MEN1 (0.31) | MEN1HCRTR1ALDH1A1LMNAMAPT | |
| SCHEMBL513868 | 0.70 | KDM4E (0.30) | ALDH1A1 | |
| SCHEMBL107094 | 0.69 | TAS1R3 (0.33) | — | |
| SCHEMBL3043216 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021009568-A1 | BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF | 2692372 ONTARIO, INC. (CA) | 2021-01-21 | — | — | WO | disclosed |